AstraZeneca Extends BioWisdom Partnership as Part of New Tox-Informatics Strategy

AstraZeneca is using BioWisdom's software platform to mine 10,000 internal toxicology reports as part of a new computational infrastructure for toxicology information and analysis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.